Shares of healthcare services provider BrightSpring Health Services (NASDAQ:BTSG)
jumped 3.3% in the afternoon session after several analysts signaled increased confidence in the company, with UBS being the latest to raise its price target. The bank maintained its "Buy" rating on the stock while lifting its price target to $35 from $31. This move was part of a broader trend of positive sentiment, following recent price target increases from firms including Wells Fargo and B of A Securities.
Adding to the optimism, analysts at TD Cowen, who also maintained a "Buy" rating, pointed to fundamental strength within the company. They highlighted expectations for strong results from BrightSpring's Pharmacy segment, helped by increased activity in certain generic drugs and new contracts for limited distribution drugs.
Explore the S&P500 index on Monday and find out which stocks are the most active in today's session. Stay updated with the stocks that are capturing market interest.
Investors are eagerly awaiting the start of earnings season for market direction, as the continued government shutdown is creating a lack of economic data
Washington D.C., October 10, 2025 – The highly anticipated 2026 Social Security Cost-of-Living Adjustment (COLA) announcement, a critical financial marker for nearly 74 million Americans, faced significant headwinds and widespread doubt in early October due to an ongoing federal government shutdown. The disruption threatened to delay the release of vital
The ongoing U.S. federal government shutdown, now in its tenth day as of October 10, 2025, has sent significant tremors through global financial markets. The persistent congressional deadlock over appropriations legislation for the 2026 fiscal year has intensified economic uncertainty worldwide, contributing to notable market losses across major indices.
Washington D.C., October 10, 2025 – The financial markets are bracing for impact as the September 2025 Consumer Price Index (CPI) report looms, a critical piece of economic data that promises to shine a harsh light on persistent inflation. This report, due for release amidst an ongoing government shutdown, is
A number of stocks fell in the afternoon session after worries over worsening trade relations with China were triggered by critical comments from President Donald Trump.
A number of stocks fell in the afternoon session after worries over worsening trade relations with China were triggered by critical comments from President Donald Trump.
Shares of telehealth company Hims & Hers Health (NYSE:HIMS) fell 6.5% in the afternoon session after a Bank of America report highlighted weakening order trends and a lowered fourth-quarter revenue forecast.
Looking for the most active stocks in the S&P500 index on Friday? Dive into today's session and discover the stocks that are dominating the trading activity and setting the pace for the market.
JPMorgan Chase & Co. (NYSE: JPM) has recently recalibrated its outlook on the biopharmaceutical giant Incyte Corporation (NASDAQ: INCY), with a notable upward revision of its price target for the company's shares. On October 9, 2025, JPMorgan analyst Jessica Fye increased Incyte's price target to $89.00, a significant jump from
New York, NY – October 9, 2025 – Pfizer Inc. (NYSE:PFE) has once again affirmed its steadfast commitment to shareholder returns, declaring a $0.43 per-share cash dividend for the fourth quarter of 2025. This latest payout marks a significant milestone: the company's 348th consecutive quarterly dividend. The unwavering consistency of
In a period marked by broader market retreats and economic uncertainties, the healthcare sector is emerging as a beacon of resilience, demonstrating its enduring defensive nature. As of October 9, 2025, while other sectors navigate choppy waters, healthcare companies are showcasing remarkable stability, largely underpinned by the essential and non-discretionary
New York, NY – October 9, 2025 – Pfizer Inc. (NYSE: PFE) has once again affirmed its steadfast commitment to shareholder returns, declaring a $0.43 per-share cash dividend for the fourth quarter of 2025. This payment marks a significant milestone as the company's 348th consecutive quarterly dividend, a testament to its
A significant surge in capital flowing into short-bias Exchange-Traded Funds (ETFs) has sent a clear signal through the financial markets: investor sentiment is shifting towards caution and a potential stock market pullback. This notable trend, particularly pronounced in recent weeks, suggests that a growing number of investors are actively positioning
The relentless ascent of the U.S. stock market has hit a significant speed bump, as both the S&P 500 and Nasdaq Composite have retreated from their recent record highs. This pullback, occurring after weeks of robust gains, signals a period of reassessment for investors grappling with a confluence
